In an early animal test, a new nasal-spray vaccine has shown promise against a variety of germs and a common allergen, ...

A Stanford University team have tested their nasal spray vaccine in animals but still need to do human clinical trials.

Researchers at Stanford University have created an experimental nasal spray, which could help protect against all kinds of respiratory infections, including the common cold, flu, and serious bacterial ...

A ‘BREAKTHROUGH’ jab that combats colds, flu, Covid and allergies in one go could be available within years, scientists say. The four-in-one jab could protect the lungs from ...

Researchers developed a nasal vaccine that provides broad protection against respiratory viruses, bacteria, and allergens in mice. Human trials are planned, raising hopes for a universal respiratory ...

It is hoped that in the next few years, the vaccine could replace multiple jabs for winter respiratory infections.

Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, has recently received clinical trial approval ...

Scientists develop universal vaccine to protect against allergies, cold and flu - The vaccine could replace multiple jabs ...

From a potential new flu vaccine to a groundbreaking surgical first and critical health reminders, here's today's essential health news.

SAN FRANCISCO -- A new type of COVID-19 therapy is showing promise as a new tool to hijack the virus and slow down variants. It's a new weapon that could be added to the arsenal against COVID-19.

Nasal drops eliminated the deadliest brain cancer in mice and activated long-lasting immune defenses that prevented the return of tumors ...